[india-drug] Response to National Pharmacovigilance Centre

["Dr.Thatte" <mthatte@vsnl.com>]

Response to National Pharmacovigilance Centre
----------------------------------------------

To Dr. Pipasha's question - the answer is simply yes.
Unfortunately, the real life situation is difficult. Making laws is 
easier said than done. Implementing them to the letter and spirit is
very difficult.
What other modes are there? I feel in addition to regulatory measures, 
some educational and managerial methods must also be used to increase 
awareness about the importance of ADR monitoring. The mechanisms of
reporting should be simple and widely advertised. Students and
residents as also practitioners of all fraternities must become
familiar with not just ADRs but relevant aspects like causality as well
as reporting ADRs.

Dr. Urmila Thatte
Dept.of Clinical Pharmacology
TN Medical College and BYL Nair Hospital
Mumbai 400 008
Tel: 91 22 301 4713
Telefax: 91 22 305 0347
e-mail clinpharm@vsnl.net


________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org